Liver Diseases  >>  Avastin (bevacizumab)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

5 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Avastin (bevacizumab) / Roche
NCT01441388: A Study Of Crizotinib Plus VEGF Inhibitor Combinations In Patients With Advanced Solid Tumors.

Withdrawn
1b
0
US
Crizotinib plus VEGF inhibitor combinations, Crizotinib plus axitinib, Crizotinib plus sunitinib, Crizotinib plus bevacizumab, Crizotinib plus sorafenib
Pfizer
Carcinoma, Renal Cell, Glioblastoma, Carcinoma, Hepatocellular
11/13
11/13
NCT00426829: Proton Therapy and Bevacizumab for Primary Liver Tumors

Terminated
1
3
US
Bevacizumab, Avastin, Anti-VEGF monoclonal antibody, rhuMAb-VEGF, Proton Radiation Therapy, PT, RT, Proton RT
M.D. Anderson Cancer Center, Genentech, Inc.
Liver Cancer, Hepatocellular Carcinoma, Cholangiocarcinoma
11/09
11/09
NCT00507585: Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, Leucovorin, and Avastin

Completed
1
63
US
Fluorouracil, 5-FU, Adrucil, Efudex, 5-fluorouracil, Avastin, Bevacizumab, Leucovorin, Oxaliplatin
M.D. Anderson Cancer Center
Liver Cancer, Advanced Solid Tumors
01/10
01/10
NCT00467194: Sirolimus and Bevacizumab in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery

Checkmark P1 data: (rapamycin + bevacizumab)
Dec 2012 - Dec 2012: P1 data: (rapamycin + bevacizumab)
Completed
1
27
RoW
Rapamycin, Bevacizumab
National Cancer Centre, Singapore
Liver Cancer
05/11
 
NCT00980239: HAI Irinotecan + IV Bevacizumab, Bevacizumab & Oxaliplatin or Bevacizumab & Cetuximab in Advanced Cancers Metastatic to Liver

Completed
1
115
US
Irinotecan, CPT-11, Camptosar, Bevacizumab, Avastin, Anti-VEGF monoclonal antibody, rhuMAb-VEGF, Oxaliplatin, Eloxatin, Cetuximab, C225, Erbitux, IMC-C225
M.D. Anderson Cancer Center
Liver Cancer, Advanced Cancer
08/15
08/15

Download Options